With the global market for biosimilars forecast to exceed $4 billion by 2015, there is intense focus on the development and commercialization of these products as a means of bringing cost-effective biologic theapeutics to patients worldwide. Join Dr. Howard L. Levine, Principal Consultant, and Dr. Susan Dana Jones, Senior Consultant, at the Biosimilars Congregation 2012 on February 24, 2012 at the Thistle Marble Arch, London, UK. This exciting conference will unite industry leaders to analyze commercial developments and identify successful management strategies for biosimilars worldwide. Drs. Levine and Jones look forward to seeing you in London. To schedule time with either of them to discuss your CMC needs, click here.